Ovagen (20 mg) (Without Mannitol)

$50.00
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.

 

Ovagen Structure
Amino Acid Sequence: Glu-Asp-Leu (EDL)
Molecular Formula: C₁5H25N3O8
Molecular Weight: 375.37 g/mol
PubChem CID: 444128
Synonyms: EDL, glutamyl-aspartyl-leucine, SCHEMBL5329396, 1a30, CHEBI:137252

Image Checkout
Guaranteed Checkout
Categories: ,
Want a discount? Become a member!

Ovagen, a tripeptide bioregulator, should not be mistaken for the similarly named Ovagen containing ovine (sheep) follicle stimulating hormone (FSH). These two products possess distinct functions and are entirely dissimilar. While the FSH derivative aids ovulation, particularly in women dealing with conditions like polycystic ovarian syndrome (PCOS), the tripeptide serves as a liver function regulator. For the context of this article, Ovagen refers to the tripeptide bioregulator.

Developed by Dr. Vladimir Khavinson, Ovagen belongs to the Khavinson peptide family, created alongside numerous other peptides. Similar to other bioregulators, Ovagen can penetrate cell and nuclear membranes, directly influencing DNA structure and transcription patterns. Exhibiting tissue-specific effects like most bioregulatory peptides, the Glu-Asp-Leu peptide primarily regulates and normalizes liver and digestive tract functions. There’s also some indication suggesting its potential usefulness in managing the replication of the HIV virus. This particular discovery has sparked interest among HIV researchers seeking insights into the virus’s lifecycle.